Immune and gene-expression profiling in estrogen receptor low and negative early breast cancerDavide Massa, Maria Vittoria Dieci, Federica Miglietta et al.|JNCI Journal of the National Cancer Institute|2024Cited by 32
1MO Tumor immune microenvironment in ER-negative vs ER-low, HER2-neg breast cancerDavide Massa, Maria Vittoria Dieci, Claudio Vernieri et al.|ESMO Open|2023Cited by 4
Abstract PO3-13-06: TILs are an independent prognostic factor in early-stage TNBC patients achieving pathologic complete response after neoadjuvant chemotherapyMaria Vittoria Dieci, Valentina Guarneri, Claudio Vernieri et al.|Cancer Research|2024Cited by 0
Abstract PO1-03-09: Transcriptomic profiling of ER-negative and ER-low, HER2-negative breast cancer and its implications on immune regulationGaia Griguolo, Maria Vittoria Dieci, Claudio Vernieri et al.|Cancer Research|2024Cited by 0